Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nuheara has commercialized multiple generations of intelligent hearing devices. Its HP Hearing PRO received FDA clearance as a self-fitting over-the-counter (OTC) medical device in late 2022. Clinical validation shows its EarID™ software provides outcomes equivalent to professionally fit devices for mild-to-moderate hearing loss. The company’s products are available through major US retailers including Best Buy, Walmart, Rite Aid, Amazon, and others.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nuheara.